Table of Contents

1. Role of Psychiatric Factors in Medical Practice 1.1 Prevalence of Mental Health and Substance Abuse Disorders 1.2 Utilization of Psychiatric Services 1.3 Functional and Economic Impact of Mental Health and Substance Abuse Disorders 1.4 Prevalence of Mental Health and Substance Abuse Disorders in Medical Practice 1.5 Psychiatric Problems in Primary Care 1.6 Impact of Mental Health and Substance Abuse Problems on Medical Costs 1.7 Cost-Benefit Issues Involving Mental Health and Substance Abuse Services 1.8 Strategic Questions for Assessing Integration of Medical and Psychiatric Services 2. Psychiatric Interview and Database 2.1 Psychiatric Interview 2.2 Psychiatric Database 2.3 Mental Status Examination (MSE) 3. Medical Evaluation of Psychiatric Symptoms 3.1 Medical Causes of Symptoms 3.2 Diagnostic Testing 4. Delirium, Dementia, Amnestic Disorders, and Other Cognitive Disorders 4.1 Delirium 4.2 Dementia 4.3 Amnestic Disorders 4.4 Cognitive Mental Status Examination 5. Alzheimer's Disease: Diagnosis and Treatment 5.1 Overview 5.2 Behavioral Symptoms of Alzheimer's Disease 5.3 Medications to Treat Agitation and Psychosis in Alzheimer's Disease 5.4 Cognitive Symptoms of Alzheimer's Disease 5.5 Anxiety in Alzheimer's Disease (Occurs in 5% to 35%) 5.6 Depression in Alzheimer's Disease 5.7 Some Common Medical Issues in Alzheimer's Disease Patients 5.8 OBRA Regulations 5.9 Resources 6. Depression: Identification and Diagnosis 6.1 General Issues of Identification 6.2 Strategy for Evaluation of Depression 6.3 Mood Disorder Due to a General Medical Condition 6.4 Major Depressive Disorder (Major Depression) 6.5 Adjustment Disorder with Depressed Mood 6.6 Dysthymic Disorder 6.7 Mixed Anxiety-Depression 6.8 Premenstrual Dysphoric Disorder (PMDD) 6.9 Minor Depression (Subthreshold Depression) 7. Antidepressants 7.1 Overview 7.2 Specific Issues in Using Antidepressants 7.3 Tricyclic Antidepressants 7.4 Second Generation Antidepressants 7.5 Uncommon (But Important) Medical Complication of the SSRIs and SNRIs 7.6 Stimulants as Antidepressants 7.7 Monoamine Oxidase Inhibitors (MAOIs) 8. Bipolar (Manic-Depressive) Disorder and Mood Stabilizing Drugs 8.1 Bipolar Disorder 8.2 Manic, Hypomanic, Mixed, Cyclothymic, and Rapid Cycling Episodes 8.3 Lithium 8.4 Valproic Acid 8.5 Carbamazepine 8.6 Oxcarbazepine 8.7 Lamotrigine 8.8 Atypical Antipsychotics 8.9 Benzodiazepines 8.10 Non-Medication Dimensions of Treatment 8.11 Electroconvulsive Therapy (ECT) 9. Anxiety Disorders: Diagnosis and Management 9.1 Overview and Background 9.2 Diagnostic Approach to Anxiety Symptoms 9.3 Panic Disorder 9.4 Obsessive-Compulsive Disorder 9.5 Generalized Anxiety Disorder 9.6 Phobias 9.7 Adjustment Disorder with Anxiety 9.8 Acute Stress Disorder 9.9 Posttraumatic Stress Disorder 10. Treatment of Anxiety: Antianxiety Medications and Behavioral Therapies 10.1 Benzodiazepines 10.2 Azapirones 10.3 Comparison of Benzodiazepines and Azapirones 10.4 Antidepressants for Anxiety 10.5 Other Sedative-Hypnotics 10.6 Cognitive-Behavoiral Therapies (CBT) 11. Sleep Problems and the Use of Hypnotics 11.1 Overview 11.2 Evaluation of Sleep Problems 11.3 Hypersomnia 11.4 Insomnia 11.5 Sleep Disorders Related to Another Mental Disorder 11.6 Sleep Disorders Associated with Medications 11.7 Parasomnias 11.8 Hypnotic Drugs 12. Psychotic Symptoms, Schizophrenia, and Antipsychotic Agents 12.1 Identification of Psychotic Symptoms 12.2 Differential Diagnosis of Psychotic Symptoms 12.3 Schizophrenia 12.4 Antipsychotic Agents Used for the Treatment of Schizophrenia and Other Psychotic Disorders 12.5 Alternatives to Antipsychotics for Psychotic Symptoms of Schizophrenia 12.6 Non-Pharmacological Aspects of Treating Schizophrenia 13. Somatoform Disorders 13.1 Overview 13.2 Somatization Disorder 13.3 Acute Somatized Symptoms 13.4 Conversion Disorder 13.5 Pain Disorder 13.6 Hypochondriasis 13.7 Body Dysmorphic Disorder 13.8 Factitious Disorder 13.9 Malingering 13.10 Somatoform Disorders Not Otherwise Specified (NOS) 14. Behavioral Emergencies: Agitation, Suicide, Violence, and Forensic Issues 14.1 Behavioral Emergencies 14.2 Suicide Evaluation 14.3 Evaluation of the Violent or Homicidal Patient 14.4 Use of Physical Restraints 14.5 Commitment Under Mental Health Statutes 14.6 Competence Evaluations 15. Alcohol and Substance Abuse 15.1 Alcohol Abuse 15.2 Alcohol Dependence 15.3 Alcohol Intoxication 15.4 Alcoholic Paranoia 15.5 Pathologic Intoxication 15.6 Wernicke-Korsakoff Syndrome (Alcohol Amnestic Syndrome) 15.7 Alcoholic Hallusinosis 15.8 Alcoholic Dementia 15.9 Hepatic Encephalopathy 15.10 Fetal Alcohol Syndrome 15.11 Alcohol Co-morbidities 15.12 Alcohol and Sedative Withdrawal 15.13 Blood Alcohol Level 15.14 Cocaine (and stimulants including amphetamine) Abuse 15.15 Hallucinogens 15.16 Issues in Narcotic Use 15.17 Psychotropics as Analgesic Augmentors 15.18 Marijuana Abuse 16. Electroconvulsive Therapy (ECT) 16.1 Overview 16.2 Indications 16.3 Contraindications 16.4 Adverse Effects 16.5 Drug Interactions 16.6 Electroconvulsive Therapy Procedure 16.7 Considerations with Specific Medical Diseases 17. Personality Disorders 17.1 Overview 17.2 Paranoid Personality Disorder 17.3 Schizoid or Schizotypal Personality Disorder 17.4 Antisocial Personality Disorder 17.5 Borderline Personality Disorder 17.6 Histrionic Personality Disorder 17.7 Narcissistic Personality Disorder 17.8 Avoidant Personality Disorder 17.9 Dependent Personality Disorder 17.10 Obsessive-Compulsive Personality Disorder 17.11 Depressive Personality Disorder 17.12 Passive-Aggressive (Negativistic) Personality Disorder 18. Eating Disorders, Obesity, and Nicotine Dependence 18.1 Anorexia Nervosa 18.2 Bullimia Nervosa 18.3 Obesity 18.4 Nicotine Dependence 19. Sexual Disorders 19.1 Phases of Sexual Function 19.2 Sexual History 19.3 Sexual Dysfunction 19.4 Paraphilias 19.5 Gender Identity Disorder 20. The P-450 System: Drug Interactions 20.1 Definition 20.2 P-450 System Terminology 20.3 Genetic Polymorphism 20.4 Age Effects 20.5 P-450 Inhibitors 20.6 P-450 Substrates 20.7 P-450 Inducers 20.8 Therapeutic Implications 21. Child and Adolescent Psychiatry 21.1 General Principles 21.2 Anxiety Disorders 21.3 Attention Deficit Hyperactivity Disorder (ADHD) 21.4 Disruptive Behavior Disorders 21.5 Depressive Disorders 21.6 Learning Disorders 21.7 Mental Retardation (MR) and Developmental Disabilities 22. Formulary

Reviews

"This is a useful tool for the clinical care of adult psychiatric patients. It can serve as a handbook in the clinical setting and residents or mental health workers on call can use this as a resource during their clinical duty hours.
The book offers clear and concise clinically relevant tables."
Adriana M. Cortes, MD(Rush University Medical Center). Doody Enterprises